A scholarly narrative on the utility of quantifying the performance of the right ventricle: the RV has been hitherto empirically assessed in many clinical setups.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
July 12, 2021
In this article, Jacobs et al. provide a multi-institutional outcomes review of 200 consecutive patients with confirmed COVID-19 supported with ECMO. The mean time on ECMO was 15 days with survival on VV-ECMO of 46.3% and survival on VA-ECMO of 25%.
2020 EACTS/ELSO/STS/AATS Expert Consensus on Post-Cardiotomy Extracorporeal Life Support in Adult Patients
April 16, 2021
A most comprehensive practice guideline, relevant not only to surgeons involved in VA ECMO, but also all cardiac and thoracic colleagues and perioperative clinicians.
Extracorporeal Life Support in COVID‐19‐Related Acute Respiratory Distress Syndrome – A EuroELSO International Survey
February 21, 2021
In this article by the COVEC Study Group, they conducted a EuroELSO international survey investigating the clinical outcomes of extracorporeal membrane oxygenation (ECMO) on patients with COVID-19 Acute Respiratory Distress Syndrome (ARDS).
Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
January 16, 2021
A recent European consensus paper. Relatively easily read, and favouring meta-analyses over randomised trials. The bulk of the manuscript is of interest to all healthcare providers. The chapters 2.8.1 and 3.1.2 are of additional relevance to the ctsnet readership, as they summarise guidance on interventions.
August 18, 2020
A review that may affect pharma strategy in the immediate future.
Graduated Compression Stockings as Adjuvant to Pharmaco-Thromboprophylaxis in Elective Surgical Patients (GAPS Study): Randomised Controlled Trial
May 15, 2020
A medium-sized RCT from the Imperial College. The research question are of interest for all cardiovascular, thoracic, and general surgeons as well as all healthcare professionals.
Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: Guidance From North American Society Leadership
May 6, 2020
This article describes recommendations from the North American leadership in regards to the safe reintroduction of cardiovascular services during the COVID-19 pandemic including, but not limited to, ethical considerations, the importance of collaboration amongst public health officials and cardiovascular specialties, and protection of healthcare work
Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes
April 16, 2020
The UNOS donor heart allocation system was revised in 2018, giving priority to patients on inpatient mechanical circulatory support (MCS). Patients admitted with heart failure-associated cardiogenic shock were tracked for the frequency of use of mechanical circulatory support before and after implementation of this change. In non-transplant center
March 26, 2020
In a cohort of 416 patients hospitalized with COVID-19, nearly 20% had elevated troponins indicating myocardial injury. These patients also had a host of other serum and radiographic abnormalities, were older, had more comorbidities, and more often required ventilatory support. Their mortality rate was 51% compared to 4.5% for other hospitalized pa